Unlimited Realities

Europe’s manufacturing sector is experiencing a quiet revolution as artificial intelligence reshapes traditional production processes. The latest company to capitalise on this convergence is Euler, which has closed a €2 million seed round to accelerate development of its AI-powered 3D printing optimisation platform. The funding signals growing investor confidence in the potential for AI to solve complex manufacturing challenges across European industrial markets. Co-led by Frumtak Ventures and Kvanted, the round reflects a strategic bet on the intersection of artificial intelligence and additive manufacturing. Both investors bring complementary expertise to Euler’s growth trajectory, with Frumtak’s deep Nordic manufacturing networks and Kvanted’s AI-focused investment thesis providing critical market access and technical guidance. AI-powered 3D printing software attracts strategic investment The investment landscape for manufacturing technology has evolved considerably over recent months, with European VCs increasingly targeting companies that address real industrial pain points rather than consumer applications. Frumtak Ventures, known for backing Nordic industrial innovators, sees Euler as positioned to capture significant value in the €12 billion European 3D printing market. “Manufacturing companies across Europe are struggling with the complexity of optimising 3D printing parameters for different materials and geometries,” noted a partner at Frumtak Ventures. “Euler’s AI approach promises to eliminate much of the trial-and-error that currently plagues industrial additive manufacturing processes.” The co-investment from Kvanted adds crucial AI expertise to Euler’s strategic support network. Kvanted’s portfolio focus on enterprise AI applications positions them to provide both capital and guidance as Euler scales its machine learning capabilities across diverse manufacturing environments. European manufacturing edge drives market expansion Euler’s technology addresses a particularly acute challenge in European manufacturing, where stringent quality standards and complex regulatory requirements demand precise control over production processes. The company’s AI platform optimises printing parameters in real-time, reducing material waste and improving part quality—critical factors for manufacturers operating under EU sustainability directives. The funding will primarily support product development and market expansion across key European manufacturing hubs, including Germany’s automotive cluster and the Netherlands’ aerospace sector. Euler plans to establish partnerships with major industrial 3D printing equipment manufacturers, positioning itself as the intelligence layer that makes additive manufacturing more predictable and cost-effective. “European manufacturers have been slower to adopt 3D printing at scale because of quality concerns and process unpredictability,” explained Euler’s CEO. “Our AI platform removes those barriers by learning from every print job and automatically adjusting parameters for optimal results.” The company faces competition from established players like Materialise and emerging AI-focused startups, but benefits from Europe’s strong industrial base and growing emphasis on localised, sustainable manufacturing. Regulatory tailwinds, including EU initiatives promoting digital manufacturing and circular economy principles, create additional market momentum for Euler’s optimisation technology. This funding round demonstrates how European deep tech companies are successfully attracting capital by addressing specific industrial challenges rather than pursuing broad consumer markets. As AI capabilities mature and manufacturing demands intensify, Euler’s focused approach to 3D printing optimisation positions it well within Europe’s evolving industrial landscape.

Nearly half of Europeans struggle with allergy misdiagnosis, creating a healthcare gap that costs both patients and systems dearly. This diagnostic challenge has caught the attention of European investors, particularly as personalised healthcare becomes increasingly prioritised across EU markets. Lithuanian startup Self.co has secured €2.56 million in funding to tackle this widespread issue, making allergy testing more accessible to European consumers. The funding round positions Self.co at the forefront of Europe’s growing digital health movement, where regulatory frameworks like the Medical Device Regulation create both opportunities and compliance requirements that favour well-prepared startups. Lithuanian startup funding round attracts European venture capital Iron Wolf Capital led this significant investment, demonstrating the growing confidence in Baltic tech innovation. The Lithuanian VC’s involvement signals a broader trend of regional capital backing local solutions to pan-European problems. Iron Wolf’s portfolio strategy focuses on B2B and healthcare technology, making Self.co a natural fit for their thesis around accessible medical solutions. “We’re seeing unprecedented demand for at-home diagnostic solutions across Europe, and Self.co’s approach to allergy testing addresses a genuine market need,” noted a representative from the investment team. The funding structure reflects typical European Series A characteristics, with local lead investors bringing both capital and market knowledge essential for navigating Europe’s fragmented healthcare systems. The investor mix suggests confidence in Self.co’s ability to scale across European markets, where healthcare regulations vary significantly between member states. This regulatory complexity often favours startups that can demonstrate compliance early in their development cycle. Digital health innovation tackles European allergy crisis Self.co’s platform addresses a critical gap in European healthcare delivery, where traditional allergy testing often requires lengthy waits and specialist appointments. The company’s solution enables consumers to conduct reliable allergy tests from home, potentially reducing the diagnostic timeline from months to days. This approach particularly resonates in Nordic and Baltic markets, where healthcare digitisation has accelerated post-pandemic. The startup competes in a growing European market that includes established players like Thriva and emerging digital health platforms. However, Self.co’s specific focus on allergy testing provides clear differentiation in a sector where specialisation often trumps broad-spectrum offerings. Their technology integrates with existing healthcare systems, crucial for adoption in Europe’s diverse medical landscapes. “Our goal is to make allergy testing as simple as checking your blood pressure at home,” explained the Self.co team regarding their European expansion strategy. The funding will primarily support product development and regulatory approvals across key EU markets, starting with Germany and the Netherlands where digital health adoption rates remain high. This investment reflects Europe’s broader shift toward preventive healthcare solutions, supported by regulatory frameworks that increasingly favour patient-centric innovation. Self.co’s timing aligns with EU digital health initiatives that prioritise accessible, data-driven medical solutions for common conditions like allergies.

As artificial intelligence transforms the financial services landscape, cybercriminals are exploiting these same technologies to orchestrate increasingly sophisticated scams against banking customers. This evolving threat has created a pressing need for advanced security solutions tailored to the European financial sector’s unique regulatory environment. Falkin, a London-based fintech security startup, has secured €1.8M ($2M) in seed funding led by TriplePoint Ventures to develop AI-powered fraud prevention tools specifically designed to protect European bank customers from next-generation scam attacks. The round positions Falkin at the forefront of a rapidly evolving cybersecurity market where traditional rule-based systems are proving inadequate against AI-enhanced threats. TriplePoint Ventures backs fintech security innovation TriplePoint Ventures’ investment in Falkin reflects the venture firm’s strategic focus on infrastructure technologies that address critical pain points in financial services. The Silicon Valley-based investor has built a reputation for backing companies that provide essential plumbing for the digital economy, making Falkin’s anti-fraud platform a natural fit for their portfolio thesis. “The sophistication of AI-powered scams has reached a tipping point where traditional fraud detection methods are no longer sufficient,” said a TriplePoint Ventures partner. “Falkin’s approach to real-time threat detection using machine learning represents the next evolution in financial security technology.” The investment comes at a time when European banks face mounting pressure from regulators to enhance customer protection measures, particularly around digital fraud prevention. The EU’s revised Payment Services Directive (PSD2) and upcoming AI Act create both compliance challenges and market opportunities for specialised security providers like Falkin. European banks embrace AI-driven fraud prevention Falkin’s platform utilises advanced machine learning algorithms to analyse transaction patterns, customer behaviour, and communication channels in real-time, identifying potential scam attempts before they can cause financial damage. The company’s European focus allows it to navigate the continent’s complex regulatory landscape while addressing the specific fraud vectors targeting UK and EU banking customers. “We’re seeing a fundamental shift in how fraudsters operate, with AI enabling them to create highly personalised and convincing scam campaigns at scale,” explained Falkin’s CEO. “Our platform is built specifically for the European market, where banks need solutions that balance robust security with strict data protection requirements.” The startup plans to use the funding to accelerate product development and expand its commercial partnerships with tier-one European banks. Falkin’s go-to-market strategy focuses initially on the UK market before expanding across the EU, leveraging existing relationships with financial institutions seeking advanced fraud prevention capabilities. This funding round signals growing investor confidence in European fintech security solutions, particularly those addressing the intersection of AI, fraud prevention, and regulatory compliance. As cybercriminals continue to weaponise artificial intelligence, startups like Falkin are positioned to become critical infrastructure providers for the European banking sector’s digital transformation.